下调和上调
脱氮酶
癌症研究
交通2
癌变
蛋白激酶B
肿瘤坏死因子α
肝细胞癌
生物
信号转导
泛素
免疫学
细胞生物学
癌症
肿瘤坏死因子受体
生物化学
遗传学
基因
作者
Nana Zhou,Chaoqin Guo,Xiangyu Li,Linglan Tu,Jingyang Du,Qiyi Qian,Juejiashan Li,Dongsheng Huang,Qiuran Xu,Xiaoliang Zheng
标识
DOI:10.1016/j.bcp.2024.116473
摘要
Ubiquitin-specific peptidase 24 (USP24), a member of the deubiquitinase family, plays an important role in tumor regulation. However, the role of USP24 in Hepatocellular carcinoma(HCC)is unknown. The aim of our study was to explore the role of USP24 in HCC to seek new therapeutic targets for HCC. In this study, we found that USP24 was aberrantly upregulated in HCC tissues and predicted poor prognosis. USP24 markedly promoted HCC proliferation and progression in vitro and in vivo. Mechanistically, USP24 binds to tumor necrosis factor receptor-associated factor 2(TRAF2) and inhibits its degradation, thereby promoting the accumulation of TRAF2. Upregulation of TRAF2 activated protein kinase B/nuclear factor kappa-B (AKT/ NF-κB) signaling pathway and promoted HCC cell survival. In addition, USP24 positively correlated with programmed cell death ligand 1(PD-L1) expression in HCC, highlighting the clinical significance of USP24 activation in tumor immune evasion. Deletion of USP24 enhanced the tumor-killing ability of CD8
科研通智能强力驱动
Strongly Powered by AbleSci AI